JP2017529322A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017529322A5 JP2017529322A5 JP2017505548A JP2017505548A JP2017529322A5 JP 2017529322 A5 JP2017529322 A5 JP 2017529322A5 JP 2017505548 A JP2017505548 A JP 2017505548A JP 2017505548 A JP2017505548 A JP 2017505548A JP 2017529322 A5 JP2017529322 A5 JP 2017529322A5
- Authority
- JP
- Japan
- Prior art keywords
- moiety
- polymer
- integer
- substituted
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims 45
- 239000002131 composite material Substances 0.000 claims 22
- 239000003795 chemical substances by application Substances 0.000 claims 16
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 125000005647 linker group Chemical group 0.000 claims 10
- 238000000746 purification Methods 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 6
- 229920000765 poly(2-oxazolines) Polymers 0.000 claims 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 239000002254 cytotoxic agent Substances 0.000 claims 2
- 231100000599 cytotoxic agent Toxicity 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 claims 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 1
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 1
- 230000021615 conjugation Effects 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 150000002019 disulfides Chemical class 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920005604 random copolymer Polymers 0.000 claims 1
- 125000001554 selenocysteine group Chemical group [H][Se]C([H])([H])C(N([H])[H])C(=O)O* 0.000 claims 1
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462031382P | 2014-07-31 | 2014-07-31 | |
| US62/031,382 | 2014-07-31 | ||
| PCT/US2015/043297 WO2016019340A1 (en) | 2014-07-31 | 2015-07-31 | Polyoxazoline antibody drug conjugates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017529322A JP2017529322A (ja) | 2017-10-05 |
| JP2017529322A5 true JP2017529322A5 (enExample) | 2018-08-30 |
| JP6704900B2 JP6704900B2 (ja) | 2020-06-03 |
Family
ID=55178936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017505548A Active JP6704900B2 (ja) | 2014-07-31 | 2015-07-31 | ポリオキサゾリン抗体薬物複合体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10071168B2 (enExample) |
| EP (1) | EP3180388A4 (enExample) |
| JP (1) | JP6704900B2 (enExample) |
| KR (1) | KR20170046141A (enExample) |
| CN (1) | CN106715533B (enExample) |
| CA (1) | CA2956709A1 (enExample) |
| WO (1) | WO2016019340A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020502226A (ja) * | 2016-12-23 | 2020-01-23 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション | 薬物の標的送達のための生体適合性の親水性ポリマーコンジュゲート |
| WO2020188323A1 (en) * | 2019-03-18 | 2020-09-24 | Khashayar Karimian | Mate and separate: a convenient and general method for the separation and purification of target molecules from biological media by phase transition of pegylated recognition agents. |
| US20220249676A1 (en) * | 2019-06-05 | 2022-08-11 | Boston Scientific Scimed, Inc. | Click chemistry capturable platinum-based antineoplastic agents |
| AU2022336664A1 (en) | 2021-09-03 | 2024-01-18 | CureVac SE | Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine |
| AU2022336209B2 (en) | 2021-09-03 | 2025-10-16 | CureVac SE | Novel lipid nanoparticles for delivery of nucleic acids |
| US20250027108A1 (en) | 2021-10-29 | 2025-01-23 | CureVac SE | Improved circular rna for expressing therapeutic proteins |
| WO2023079524A2 (en) * | 2021-11-08 | 2023-05-11 | Life Technologies As | Polymer-interaction molecule conjugates and methods of use |
| US20250099614A1 (en) | 2022-01-28 | 2025-03-27 | CureVac SE | Nucleic acid encoded transcription factor inhibitors |
| WO2023212621A1 (en) * | 2022-04-26 | 2023-11-02 | University Of Virginia Patentfoundation | Development of nano-encapsulated fatty-acyl conjugated colchicine |
| AU2024233180A1 (en) | 2023-03-08 | 2025-09-25 | CureVac SE | Novel lipid nanoparticle formulations for delivery of nucleic acids |
| WO2024230934A1 (en) | 2023-05-11 | 2024-11-14 | CureVac SE | Therapeutic nucleic acid for the treatment of ophthalmic diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8871720B2 (en) | 2005-07-07 | 2014-10-28 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus |
| US20140011964A1 (en) | 2007-02-28 | 2014-01-09 | Serina Therapeutics, Inc. | Activated Polyoxazolines and Conjugates and Compositions Comprising the Same |
| CN106046370A (zh) * | 2007-02-28 | 2016-10-26 | 塞瑞纳治疗公司 | 聚噁唑啉poz化合物、合成其的方法、以及靶分子‑poz偶联物 |
| US8101706B2 (en) | 2008-01-11 | 2012-01-24 | Serina Therapeutics, Inc. | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same |
| CN101959934B (zh) * | 2008-01-11 | 2012-12-12 | 塞瑞纳治疗公司 | 聚噁唑啉共聚物的多官能形式和包含它的药物组合物 |
| MX2011003117A (es) * | 2008-09-19 | 2011-04-21 | Nektar Therapeutics | Conjugados polimericos de peptidos terapeuticos. |
| US20110256157A1 (en) * | 2010-04-15 | 2011-10-20 | Spirogen Limited | Pyrrolobenzodiazepines and conjugates thereof |
| WO2013020005A2 (en) | 2011-08-03 | 2013-02-07 | Anp Technologies, Inc. | Oxazoline polymer compositions and use thereof |
| US8383093B1 (en) | 2011-11-01 | 2013-02-26 | Serina Therapeutics, Inc. | Subcutaneous delivery of poly(oxazoline) conjugates |
-
2015
- 2015-07-31 CN CN201580052259.3A patent/CN106715533B/zh active Active
- 2015-07-31 WO PCT/US2015/043297 patent/WO2016019340A1/en not_active Ceased
- 2015-07-31 US US14/815,718 patent/US10071168B2/en active Active
- 2015-07-31 JP JP2017505548A patent/JP6704900B2/ja active Active
- 2015-07-31 EP EP15826412.7A patent/EP3180388A4/en not_active Withdrawn
- 2015-07-31 KR KR1020177005598A patent/KR20170046141A/ko not_active Withdrawn
- 2015-07-31 CA CA2956709A patent/CA2956709A1/en not_active Abandoned
-
2018
- 2018-09-10 US US16/126,798 patent/US11065340B2/en active Active